Salvage Therapy for Refractory Aids-Related Primary Central Nervous System Lymphoma
A 27-year-old male patient presented with speech disorders and multiple brain masses on MRI evaluation. He tested positive for HIV. A sterotactic biopsy diagnosed primary central nervous system lymphoma (diffuse large B-cell lymphoma). After two cycles of high-dose metotrexate (HD-MTX-)-based chemot...
Saved in:
Main Authors: | Hugo Ferro, Eduardo Parino |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/343491 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Masquerade Syndrome of Multicentre Primary Central Nervous System Lymphoma
by: Silvana Guerriero, et al.
Published: (2011-01-01) -
Molecular Mechanisms and Therapeutic Prospects of Immunotherapy and Targeted Therapy in Primary Central Nervous System Lymphoma
by: Lin Zhong MM, et al.
Published: (2025-02-01) -
Primary central nervous system lymphoma: Comprehension of cell-of-origin subtypes
by: Shruti Rao, et al.
Published: (2023-07-01) -
Unusual Relapse of Primary Central Nervous System Lymphoma at Site of Lumbar Puncture
by: Zartaj Ahmed, et al.
Published: (2014-01-01) -
Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma
by: Jiaying Wu, et al.
Published: (2024-11-01)